Literature DB >> 29792354

Challenges with biomarkers in cancer drug discovery and development.

Ecaterina Ileana Dumbrava1, Funda Meric-Bernstam1,2,3, Timothy A Yap1,2,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29792354     DOI： 10.1080/17460441.2018.1479740

Source DB:  PubMed          Journal:  Expert Opin Drug Discov        ISSN： 1746-0441            Impact factor:   6.098


× No keyword cloud information.
  10 in total

1.  Flexible Sensing Systems for Cancer Diagnostics.

Authors:  Anne K Brooks; Sudesna Chakravarty; Vamsi K Yadavalli
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

2.  A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids.

Authors:  Nhan Phan; Jenny J Hong; Bobby Tofig; Matthew Mapua; David Elashoff; Neda A Moatamed; Jin Huang; Sanaz Memarzadeh; Robert Damoiseaux; Alice Soragni
Journal:  Commun Biol       Date:  2019-02-25

3.  Efficacy gap between phase II and subsequent phase III studies in oncology.

Authors:  Rick A Vreman; Svetlana V Belitser; Ana T M Mota; Anke M Hövels; Wim G Goettsch; Kit C B Roes; Hubert G M Leufkens; Aukje K Mantel-Teeuwisse
Journal:  Br J Clin Pharmacol       Date:  2020-02-21       Impact factor: 4.335

Review 4.  Beyond chemoradiotherapy: improving treatment outcomes for patients with stage III unresectable non-small-cell lung cancer through immuno-oncology and durvalumab (Imfinzi®▼, AstraZeneca UK Limited).

Authors:  Priyanka Patel; Doraid Alrifai; Fiona McDonald; Martin Forster
Journal:  Br J Cancer       Date:  2020-12       Impact factor: 7.640

5.  A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications.

Authors:  Umesh Kathad; Aditya Kulkarni; Joseph Ryan McDermott; Jordan Wegner; Peter Carr; Neha Biyani; Rama Modali; Jean-Philippe Richard; Panna Sharma; Kishor Bhatia
Journal:  BMC Bioinformatics       Date:  2021-03-02       Impact factor: 3.169

6.  Molecular Modelling a Key Method for Potential Therapeutic Drug Discovery.

Authors:  Omar Karkoutly; Anupam Dhasmana; Vijian Dhevan; Subhash C Chauhan; Manish K Tripathi
Journal:  Biomed J Sci Tech Res       Date:  2021-07-23

Review 7.  Antibody Drug Conjugates in Glioblastoma - Is There a Future for Them?

Authors:  Sagun Parakh; Joseph Nicolazzo; Andrew M Scott; Hui Kong Gan
Journal:  Front Oncol       Date:  2021-12-03       Impact factor: 6.244

8.  Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect.

Authors:  Jeroen A C M Goos; Andrew Cho; Lukas M Carter; Thomas R Dilling; Maria Davydova; Komal Mandleywala; Simon Puttick; Abhishek Gupta; William S Price; John F Quinn; Michael R Whittaker; Jason S Lewis; Thomas P Davis
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

9.  Multiple Tolerization Subtractive Immunization (MTSI) Protocol: Effects on Mice and Monoclonal Antibody Specificity.

Authors:  Marina de Lima Fontes; Franciny Mara de Lima Neves; Kelvin Sousa Santos; Ana Marisa Fusco-Almeida; Maria José Soares Mendes Giannini; Sergio Luis Felisbino; Elenice Deffune; Andrei Moroz
Journal:  Front Immunol       Date:  2021-12-07       Impact factor: 7.561

Review 10.  Harnessing cell-free DNA: plasma circulating tumour DNA for liquid biopsy in genitourinary cancers.

Authors:  Manuel Caitano Maia; Meghan Salgia; Sumanta K Pal
Journal:  Nat Rev Urol       Date:  2020-03-17       Impact factor: 14.432
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.